ES2125935T3 - Derivados fosfolipidicos que contienen elementos superiores del quinto grupo principal. - Google Patents

Derivados fosfolipidicos que contienen elementos superiores del quinto grupo principal.

Info

Publication number
ES2125935T3
ES2125935T3 ES93114671T ES93114671T ES2125935T3 ES 2125935 T3 ES2125935 T3 ES 2125935T3 ES 93114671 T ES93114671 T ES 93114671T ES 93114671 T ES93114671 T ES 93114671T ES 2125935 T3 ES2125935 T3 ES 2125935T3
Authority
ES
Spain
Prior art keywords
main group
phospholipidic
derivatives containing
containing higher
higher elements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93114671T
Other languages
English (en)
Inventor
Jurgen Prof Engel
Peter Dr Hilgard
Bernhard Dr Kutscher
Gerhard Dr Nossner
Jurij Dr Stekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2125935T3 publication Critical patent/ES2125935T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/72—Aliphatic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCRIBEN DERIVADOS FOSFOLIPIDOS, QUE CONTIENEN ELEMENTOS MAS ALTOS (P, AS, SB, BI) DEL GRUPO PRINCIPAL V. SU PROCESO DE ELABORACION Y LOS MEDICAMENTOS ACTIVOS ANTIMICROBIALES Y ANTINEOPLASTICOS, FABRICABLES A PARTIR DE LOS DERIVADOS FOSFOLIPIDOS.
ES93114671T 1992-10-01 1993-09-13 Derivados fosfolipidicos que contienen elementos superiores del quinto grupo principal. Expired - Lifetime ES2125935T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233044A DE4233044A1 (de) 1992-10-01 1992-10-01 Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten

Publications (1)

Publication Number Publication Date
ES2125935T3 true ES2125935T3 (es) 1999-03-16

Family

ID=6469408

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93114671T Expired - Lifetime ES2125935T3 (es) 1992-10-01 1993-09-13 Derivados fosfolipidicos que contienen elementos superiores del quinto grupo principal.

Country Status (23)

Country Link
US (2) US5449798A (es)
EP (1) EP0594999B1 (es)
JP (1) JP3688304B2 (es)
KR (1) KR100331367B1 (es)
CN (1) CN1055697C (es)
AT (1) ATE174030T1 (es)
AU (1) AU661795B2 (es)
BR (1) BR9303990A (es)
CA (1) CA2107439C (es)
DE (2) DE4233044A1 (es)
DK (1) DK0594999T3 (es)
EG (1) EG20258A (es)
ES (1) ES2125935T3 (es)
FI (1) FI111261B (es)
GR (1) GR3029423T3 (es)
HU (1) HU220593B1 (es)
IL (1) IL107141A (es)
MX (1) MX9306076A (es)
NO (1) NO305911B1 (es)
PH (1) PH29951A (es)
RU (1) RU2126413C1 (es)
UA (1) UA39163C2 (es)
ZA (1) ZA937282B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP026997A0 (en) 1997-11-07 1997-12-04 Resmed Limited Administration of cpap treatment pressure in presence of apnea
US20060116354A1 (en) * 2003-01-09 2006-06-01 Perkins Walter R Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
CN103880876A (zh) * 2004-07-09 2014-06-25 脉管生物生长有限公司 制备氧化磷脂的改进方法
CA2632449A1 (en) 2005-12-19 2007-06-28 Aeterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177216A (en) * 1974-06-21 1979-12-04 The Dow Chemical Company Novel tributyl (2,5-dihydroxyphenyl)phosphonium hydroxide inner salts
US4177716A (en) * 1978-02-21 1979-12-11 Gerald J. Bowe Automatic energy saver and fire damper for exhaust systems
US4444766A (en) * 1980-10-21 1984-04-24 Boehringer Mannheim Gmbh Sulfur-containing phospholipid compounds and therapeutic compositions
US4534899A (en) * 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
AT383130B (de) * 1984-05-15 1987-05-25 Chemie Linz Ag Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate

Also Published As

Publication number Publication date
KR100331367B1 (ko) 2002-11-13
PH29951A (en) 1996-09-16
BR9303990A (pt) 1994-06-14
UA39163C2 (uk) 2001-06-15
ATE174030T1 (de) 1998-12-15
RU2126413C1 (ru) 1999-02-20
AU4874793A (en) 1994-04-14
JP3688304B2 (ja) 2005-08-24
DK0594999T3 (da) 1999-08-16
EG20258A (en) 1998-05-31
CN1088583A (zh) 1994-06-29
NO933505L (no) 1994-04-05
CN1055697C (zh) 2000-08-23
DE59309182D1 (de) 1999-01-14
DE4233044A1 (de) 1994-04-07
US5449798A (en) 1995-09-12
IL107141A (en) 1998-01-04
NO933505D0 (no) 1993-09-30
CA2107439A1 (en) 1994-04-02
JPH06199876A (ja) 1994-07-19
HU9302772D0 (en) 1993-12-28
IL107141A0 (en) 1993-12-28
EP0594999B1 (de) 1998-12-02
EP0594999A1 (de) 1994-05-04
MX9306076A (es) 1994-05-31
GR3029423T3 (en) 1999-05-28
KR940009201A (ko) 1994-05-20
NO305911B1 (no) 1999-08-16
CA2107439C (en) 2006-08-15
HUT65681A (en) 1994-07-28
FI111261B (fi) 2003-06-30
HU220593B1 (hu) 2002-03-28
FI934297A0 (fi) 1993-09-30
FI934297L (fi) 1994-04-02
AU661795B2 (en) 1995-08-03
ZA937282B (en) 1994-04-25
US5637577A (en) 1997-06-10

Similar Documents

Publication Publication Date Title
DK398587A (da) Antitumorvirksomt laegemiddel
ES531978A0 (es) Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona.
ES2084702T3 (es) Imidazoles sustituidos utiles como inhibidores de la angiotensina ii.
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
PT83961B (pt) Processo para a preparacao de derivados da pirazolina e de composicoes insecticidas e acaricidas que os contem
SG70587G (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
ES2146297T3 (es) Nuevos derivados del benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2102144T3 (es) Nuevos derivados de estradieno de 11-benzaldoxima-17beta metoxi-17alfa-metoximetilo un procedimiento para su produccion y productos medicinales que contienen estos compuestos.
FR2379514A1 (fr) Composes herbicides a base de sulfonates et leurs procedes de preparation et d'application
EP0610519A4 (en) Anti-hiv drug.
ES2125935T3 (es) Derivados fosfolipidicos que contienen elementos superiores del quinto grupo principal.
IT8323058A0 (it) Derivati di 2,5-piperazindione biologicamente attivi, processi per la loro preparazione e composizioni farmaceutiche che licontengono.
SE8302979D0 (sv) Piperazine derivatives, their production and pharmaceutical compositions containing them
MX9201944A (es) Formulacion farmaceutica que contiene diritromicina.
ES532645A0 (es) Una tableta farmaceutica de liberacion controlada
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2062794T3 (es) Derivados de (alquiltio-3 propil)-3 benzotiazolina, su preparacion y los medicamentos que les contienen.
ES2147271T3 (es) Eteres de oximas triciclicas, sus procedimentos de preparacion y las composiciones farmaceuticas que los contienen.
ES2147825T3 (es) Derivados tetraciclicos de la 1,4-oxazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69310889D1 (de) Hochdosierte Vitamine A-Zusammensetzungen
FI911982A7 (fi) Sytotoksisia bisyklo(7.3.1.)tridek-4-eeni-2,6-diyyni-yhdisteitä ja menetelmä niiden valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 594999

Country of ref document: ES